Ronell Bologna‐Molina

Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors

Ronell Bologna‐Molina, Adalberto Mosqueda‐Taylor, Nelly Molina‐Frechero et al. · Medicina oral, patología oral y cirugía bucal · 2012 · 252 citations · Full text

Medicine, Oncology, Pathology +16

Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas

Ronell Bologna‐Molina, Adalberto Mosqueda‐Taylor, Eduardo López‐Corella et al. · Oral Oncology · 2008 · 83 citations

Medicine, Oncology, Pathology +14

Comparative expression of syndecan‐1 and Ki‐67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma

Ronell Bologna‐Molina, Adalberto Mosqueda‐Taylor, Eduardo López‐Corella et al. · Pathology International · 2009 · 62 citations

Veterinary Medicine, Oncology, Pathology +17

Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review

Rogelio González‐González, Sandra López‐Verdín, Jesús Lavalle‐Carrasco et al. · World Journal of Clinical Oncology · 2019 · 57 citations · Full text

Medicine, Cancer Biology, Oncology +17

Papillary Thyroid Carcinoma: Differential Diagnosis and Prognostic Values of Its Different Variants: Review of the Literature

Rogelio González‐González, Ronell Bologna‐Molina, Ramón Gil Carreón-Burciaga et al. · ISRN Oncology · 2011 · 54 citations · Full text

Medicine, Oncology, Pathology +16